Stock Analysis News 31 October 2025

Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Stock Price Performance (as of Nov 4, 2025) Alarum Technologies (NYSE: ALAR) has rallied strongly in 2025. After closing around $16.25 on Nov 3 Stockinvest, the stock is off its all-time high (~$18.00) but still stands well above its 2024

4 November 2025

Analyst Opinions·Artificial Intelligence·Investment Opportunities·Market Trends·Stock Analysis

CAVA Group Stock: 20% Growth vs 60% Plunge – What’s Really Happening?

Stock Price & Recent Performance Cava’s stock has fallen sharply in 2025. After peaking near $172 in late 2024, it traded around $51.7 at the Nov. 4, 2025 close Stockanalysis. That marks a roughly 60% drop from its high and

4 November 2025

Financial News·Growth Stocks·Investment Strategies·Market Trends·Stock Analysis

Plug Power Stock Skyrockets on Hydrogen Hype – Will PLUG Keep Soaring? (Nov 2025 Update)

Plug Power Stock Forecast: Will PLUG Soar or Slip by End of 2025?

Recent Price Action and Technical Trends Plug Power’s stock chart in 2025 tells a rollercoaster story. After languishing below $1 per share in mid-year, PLUG staged a stunning comeback in late summer and early fall. From August to early October,

4 November 2025

Investing·Market Trends·Renewable Energy·Stock Analysis

AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

Company & Stock Overview AT&T Inc. is a telecom giant with a 140+ year legacy, now focused squarely on connectivity services. Its business model centers on providing voice and data communication to consumers and businesses via an expansive wireless network

4 November 2025

5G Technology·Dividends·Investment Strategies·Stock Analysis·Telecommunications

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This

4 November 2025

Biotechnology·Investment Insights·Pharmaceutical Industry·Stock Analysis

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their tumor, are expanded and activated in a lab,

3 November 2025

Biotech·Cancer Research·Stock Analysis

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicine Stockanalysis. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core

3 November 2025

Biotechnology·Cancer Research·Healthcare Innovation·Stock Analysis

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

Company Overview & Business Segments IDEXX Laboratories facility in Markham, Canada (one of the company’s global offices). IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and

3 November 2025

Investment Insights·Stock Analysis

Chipotle Stock’s Worst Slump Since 2012 – Bulls and Bears Clash on CMG’s Future

Current Stock Price and Recent Performance A Chipotle Mexican Grill storefront. The burrito chain’s shares suffered a sharp sell-off in late October 2025. Chipotle’s stock has been reeling in the wake of its Q3 report. After closing at $39.76 just

2 November 2025

Company News·Market Trends·Stock Analysis

Rani Therapeutics (RANI) Stock Skyrockets ~200% on $1B Pharma Deal – Will the Rally Last?

Rani Therapeutics Stock Explodes on Obesity-Drug Breakthrough – Analysts Eye $10+ Targets

Stock Performance and Recent Movement Rani shares have exploded in the last month. On Oct 1, 2025 RANI traded around $0.50. A landmark collaboration announced Oct 17 with Japan’s Chugai (up to $1.085B deal) and a simultaneous $60M financing sent

1 November 2025

Biotech·Pharmaceuticals·Stock Analysis

AI Goldmine or Next Bubble? Inside Credo (CRDO) Stock’s 1300% Surge and Future Outlook

Latest Stock Price and Momentum Credo (NASDAQ: CRDO) has been on a tear in late 2025, with its stock price around $188 as of October 31, 2025. This represents a ~12% jump in one day and extends a powerful rally

31 October 2025

AI Stocks·Investment Insights·Market Trends·Stock Analysis·Technology News

Arbor Realty Trust’s 12% Dividend: Golden Opportunity or Yield Trap in 2025?

1. Company Overview Arbor Realty Trust, Inc. is a specialized real estate finance company operating as an externally-managed REIT. Founded in 2003 and headquartered in Uniondale, NY, Arbor’s business is centered on originating, investing in, and servicing real estate loans

31 October 2025

Dividend Stocks·Financial Planning·Stock Analysis

Stock Analysis News 31 October 2025 - 4 November 2025